Literature DB >> 22232165

Activation of legumain involves proteolytic and conformational events, resulting in a context- and substrate-dependent activity profile.

Elfriede Dall1, Hans Brandstetter.   

Abstract

Localized mainly to endo/lysosomes, legumain plays an important role in exogenous antigen processing and presentation. The cysteine protease legumain, also known as asparaginyl endopepetidase AEP, is synthesized as a zymogen and is known to undergo pH-dependent autoproteolytic activation whereby N-terminal and C-terminal propeptides are released. However, important mechanistic details of this pH-dependent activation as well as the characteristic pH activity profile remain unclear. Here, it is shown that all but one of the autocatalytic cleavage events occur in trans, with only the release of the C-terminal propeptide being relevant to enzymatic activity. An intriguing super-activation event that appears to be exclusively conformational in nature and enhances the enzymatic activity of proteolytically fully processed legumain by about twofold was also found. Accepting asparagines and, to lesser extent, aspartic acid in P1, super-activated legumain exhibits a marked pH dependence that is governed by the P1 residue of its substrate and conformationally stabilizing factors such as temperature or ligands. The crystallization and preliminary diffraction data analysis of active legumain are presented, which form an important basis for further studies that should clarify fundamental aspects of activation, activity and inactivation of legumain, which is a key target in (auto-)immunity and cancer.
© 2012 International Union of Crystallography. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22232165      PMCID: PMC3253828          DOI: 10.1107/S1744309111048020

Source DB:  PubMed          Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun        ISSN: 1744-3091


  40 in total

1.  Deletion mutagenesis of large (12-kb) plasmids by a one-step PCR protocol.

Authors:  J Wang; M F Wilkinson
Journal:  Biotechniques       Date:  2001-10       Impact factor: 1.993

2.  Activation of Arabidopsis vacuolar processing enzyme by self-catalytic removal of an auto-inhibitory domain of the C-terminal propeptide.

Authors:  Miwa Kuroyanagi; Mikio Nishimura; Ikuko Hara-Nishimura
Journal:  Plant Cell Physiol       Date:  2002-02       Impact factor: 4.927

Review 3.  Evolutionary lines of cysteine peptidases.

Authors:  A J Barrett; N D Rawlings
Journal:  Biol Chem       Date:  2001-05       Impact factor: 3.915

4.  Destructive processing by asparagine endopeptidase limits presentation of a dominant T cell epitope in MBP.

Authors:  Bénédicte Manoury; Daniela Mazzeo; Lars Fugger; Nick Viner; Mary Ponsford; Heather Streeter; Graziella Mazza; David C Wraith; Colin Watts
Journal:  Nat Immunol       Date:  2002-01-14       Impact factor: 25.606

5.  Substrate specificity of schistosome versus human legumain determined by P1-P3 peptide libraries.

Authors:  Mary A Mathieu; Matthew Bogyo; Conor R Caffrey; Youngchool Choe; Jewok Lee; Harold Chapman; Mohammed Sajid; Charles S Craik; James H McKerrow
Journal:  Mol Biochem Parasitol       Date:  2002-04-30       Impact factor: 1.759

6.  Activation of progelatinase A by mammalian legumain, a recently discovered cysteine proteinase.

Authors:  J M Chen; M Fortunato; R A Stevens; A J Barrett
Journal:  Biol Chem       Date:  2001-05       Impact factor: 3.915

7.  Activation of human prolegumain by cleavage at a C-terminal asparagine residue.

Authors:  J M Chen; M Fortunato; A J Barrett
Journal:  Biochem J       Date:  2000-12-01       Impact factor: 3.857

8.  Osteoclast inhibitory peptide 2 inhibits osteoclast formation via its C-terminal fragment.

Authors:  S J Choi; N Kurihara; Y Oba; G D Roodman
Journal:  J Bone Miner Res       Date:  2001-10       Impact factor: 6.741

9.  iMOSFLM: a new graphical interface for diffraction-image processing with MOSFLM.

Authors:  T Geoff G Battye; Luke Kontogiannis; Owen Johnson; Harold R Powell; Andrew G W Leslie
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2011-03-18

10.  Non-pathogenic trypanosomatid protozoa as a platform for protein research and production.

Authors:  Reinhard Breitling; Susanne Klingner; Nico Callewaert; Regina Pietrucha; Anett Geyer; Gunter Ehrlich; Regina Hartung; Angelika Müller; Roland Contreras; Stephen M Beverley; Kirill Alexandrov
Journal:  Protein Expr Purif       Date:  2002-07       Impact factor: 1.650

View more
  34 in total

1.  Progress toward sourcing plants for new bioconjugation tools: a screening evaluation of a model peptide ligase using a synthetic precursor.

Authors:  Tunjung Mahatmanto; Isyatul Azizah; Alex Buchberger; Nicholas Stephanopoulos
Journal:  3 Biotech       Date:  2019-11-09       Impact factor: 2.406

2.  Mechanistic and structural studies on legumain explain its zymogenicity, distinct activation pathways, and regulation.

Authors:  Elfriede Dall; Hans Brandstetter
Journal:  Proc Natl Acad Sci U S A       Date:  2013-06-17       Impact factor: 11.205

3.  Structural analysis of asparaginyl endopeptidase reveals the activation mechanism and a reversible intermediate maturation stage.

Authors:  Lixia Zhao; Tian Hua; Christopher Crowley; Heng Ru; Xiangmin Ni; Neil Shaw; Lianying Jiao; Wei Ding; Lu Qu; Li-Wei Hung; Wei Huang; Lei Liu; Keqiang Ye; Songying Ouyang; Genhong Cheng; Zhi-Jie Liu
Journal:  Cell Res       Date:  2014-01-10       Impact factor: 25.617

Review 4.  Proteolysis mediated by cysteine cathepsins and legumain-recent advances and cell biological challenges.

Authors:  Klaudia Brix; Joseph McInnes; Alaa Al-Hashimi; Maren Rehders; Tripti Tamhane; Mads H Haugen
Journal:  Protoplasma       Date:  2014-11-16       Impact factor: 3.356

5.  Protease cleavage site fingerprinting by label-free in-gel degradomics reveals pH-dependent specificity switch of legumain.

Authors:  Robert Vidmar; Matej Vizovišek; Dušan Turk; Boris Turk; Marko Fonović
Journal:  EMBO J       Date:  2017-07-21       Impact factor: 11.598

6.  Counter Selection Substrate Library Strategy for Developing Specific Protease Substrates and Probes.

Authors:  Marcin Poreba; Rigmor Solberg; Wioletta Rut; Ngoc Nguyen Lunde; Paulina Kasperkiewicz; Scott J Snipas; Marko Mihelic; Dusan Turk; Boris Turk; Guy S Salvesen; Marcin Drag
Journal:  Cell Chem Biol       Date:  2016-07-28       Impact factor: 8.116

7.  Crystal Structure of Plant Legumain Reveals a Unique Two-Chain State with pH-Dependent Activity Regulation.

Authors:  Florian B Zauner; Elfriede Dall; Christof Regl; Luigi Grassi; Christian G Huber; Chiara Cabrele; Hans Brandstetter
Journal:  Plant Cell       Date:  2018-02-16       Impact factor: 11.277

8.  Legumain Induces Oral Cancer Pain by Biased Agonism of Protease-Activated Receptor-2.

Authors:  Nguyen Huu Tu; Dane D Jensen; Bethany M Anderson; Elyssa Chen; Nestor N Jimenez-Vargas; Nicole N Scheff; Kenji Inoue; Hung D Tran; John C Dolan; Tamaryn A Meek; Morley D Hollenberg; Cheng Z Liu; Stephen J Vanner; Malvin N Janal; Nigel W Bunnett; Laura E Edgington-Mitchell; Brian L Schmidt
Journal:  J Neurosci       Date:  2020-11-10       Impact factor: 6.167

9.  Activation Mechanism of the Bacteroides fragilis Cysteine Peptidase, Fragipain.

Authors:  Julien Herrou; Vivian M Choi; Juliane Bubeck Wardenburg; Sean Crosson
Journal:  Biochemistry       Date:  2016-07-12       Impact factor: 3.162

10.  Legumain is activated in macrophages during pancreatitis.

Authors:  Laura E Edgington-Mitchell; Thomas Wartmann; Alicia K Fleming; Vasilena Gocheva; Wouter A van der Linden; Nimali P Withana; Martijn Verdoes; Luigi Aurelio; Daniel Edgington-Mitchell; TinaMarie Lieu; Belinda S Parker; Bim Graham; Thomas Reinheckel; John B Furness; Johanna A Joyce; Peter Storz; Walter Halangk; Matthew Bogyo; Nigel W Bunnett
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2016-08-11       Impact factor: 4.052

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.